PolyPid Ltd.
- PYPD
- NASDAQ
- Biotechnology
- Drug Delivery Platform (PLEX)
- Infectious Disease Therapeutics
$4.72
Today −3.67%Quote Oct 16, 2026, 08:00 PM UTC
−6.16%over the last month
Max drawdown −13.4%From 1-month high −13.4%3 months −8.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$85.9M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$12.50
+164.8% from here
Floor
$4.47
5.3% below price
Where the price sits
9 analysts
Analyst range, low to high
$12.00$13.00
- Price $4.72
- Resistance $4.75
- Consensus $12.50
The price is right under resistance. Analysts' average target sits about 165% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PYPDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
72